Longest acting drug among the following drugs for over reactive bladder:
**Core Concept**
The question is testing the understanding of pharmacological agents used in the management of overactive bladder, specifically the duration of action of these drugs. Overactive bladder is a condition characterized by urgency, frequency, and nocturia, often secondary to detrusor overactivity. The treatment involves pharmacological agents that target the muscarinic receptors in the bladder.
**Why the Correct Answer is Right**
The longest acting drug among the options is likely to be a muscarinic receptor antagonist with a long half-life. The correct answer, **Mirabegron**, is a beta-3 adrenergic receptor agonist that relaxes the detrusor muscle and increases bladder capacity. It has a longer duration of action compared to other options, making it suitable for once-daily administration. Mirabegron's mechanism of action is distinct from other overactive bladder treatments, which often involve muscarinic receptor antagonists like tolterodine or oxybutynin.
**Why Each Wrong Option is Incorrect**
**Option A:** is incorrect because it is not a well-known treatment for overactive bladder. **Option B:** is incorrect because it is an anticholinergic agent with a shorter duration of action compared to Mirabegron. **Option D:** is incorrect because it is a different class of medications used for a different indication.
**Clinical Pearl / High-Yield Fact**
Mirabegron is a beta-3 adrenergic receptor agonist, which is a distinct class of medications compared to anticholinergic agents. This makes it an attractive option for patients with overactive bladder who experience side effects with traditional treatments.
**Correct Answer: C. Mirabegron**